CTL for supertype natural IGE cytotoxic peptide (necp) to guard against allergic asthma
Ended Project Grant Awarded Last action
- Award ID
- R44AI122358
- Recipient
-
IGE Therapeutics Inc. UEI XF2MYFW5XPD5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,258,938
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $549,186 | |
| Amendment | $856,276 | |
| Original award | $853,476 |
Quick answers
Who received award R44AI122358?
R44AI122358 was awarded to IGE Therapeutics Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 15, 2016.
How much is award R44AI122358 worth?
$2,258,938 has been obligated on R44AI122358.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award